News Quantified

CDNA – caredx, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Are Medical Stocks Lagging CareDx (CDNA) This Year? [Yahoo! Finance]

CareDx to Participate in Upcoming Investor Conferences

Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 [Yahoo! Finance]

CareDx Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at BTIG Research from $40.00 to $35.00. They now have a "buy" rating on the stock.

-0.1%

BEAT

18.0%

BEAT

34.1%

BEAT

12.1%

BEAT

Form SC 13G/A CareDx, Inc. Filed by: Bellevue Asset Management (UK) Ltd.

Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam

Form SC 13G/A CareDx, Inc. Filed by: Nikko Asset Management Americas, Inc.

Form 4 CareDx, Inc. For: Nov 01 Filed by: Bickerstaff George

Form 4 CareDx, Inc. For: Nov 01 Filed by: Novack Jeffrey Adam

Top News Gainers

3/13 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 17.3%

4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%

5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%

1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%

4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%

9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%

10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%

5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%

3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%

6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%

Top News Decliners

3/16 Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter -19.3%

7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%

8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%

10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%

11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%

3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%

6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%

8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%

7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%

10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day